Tag: Jennifer Doudna
October 5, 2017
4 Gene Therapy Stocks to Watch in 2017
At the halfway mark of 2017, here's a look at how these four gene therapy companies are performing so far...
February 21, 2017
Thom Calandra: Investing in Gene-editing Stocks
Thom Calandra is known to investors in the resource space. Recently, he wrote about biotechnology and started his own index...
February 15, 2017
The CRISPR-Cas9 Patent Dispute
The US Patent Office has ruled “no interference in fact” on CRISPR-Cas9 Patent dispute.
November 3, 2016
Best Regions for Genetics Research
The US, China and the UK are the top regions for genetics research.
March 10, 2016